Rolf Beume

1.5k total citations
28 papers, 1.2k citations indexed

About

Rolf Beume is a scholar working on Physiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rolf Beume has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 14 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rolf Beume's work include Asthma and respiratory diseases (17 papers), Phosphodiesterase function and regulation (13 papers) and Respiratory and Cough-Related Research (4 papers). Rolf Beume is often cited by papers focused on Asthma and respiratory diseases (17 papers), Phosphodiesterase function and regulation (13 papers) and Respiratory and Cough-Related Research (4 papers). Rolf Beume collaborates with scholars based in Germany, Italy and Switzerland. Rolf Beume's co-authors include Lutz Wollin, Armin Hatzelmann, Giuseppe Lungarella, Hermann Tenor, Christian Schudt, Monica Lucattelli, Piero A. Martorana, Manfrid Eltze, Daniela S. Bundschuh and Johannes Barsig and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Allergy and Clinical Immunology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Rolf Beume

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rolf Beume Germany 15 679 618 533 221 148 28 1.2k
Hermann Tenor Germany 18 587 0.9× 405 0.7× 385 0.7× 221 1.0× 140 0.9× 26 1.1k
M A Giembycz United Kingdom 20 514 0.8× 527 0.9× 308 0.6× 240 1.1× 111 0.8× 28 1.0k
L. Daffonchio Italy 18 176 0.3× 405 0.7× 351 0.7× 152 0.7× 81 0.5× 65 932
Piper Pj United Kingdom 13 159 0.2× 401 0.6× 272 0.5× 101 0.5× 361 2.4× 43 1.0k
Stephen M. Spaethe United States 17 179 0.3× 454 0.7× 260 0.5× 210 1.0× 85 0.6× 48 829
Monika Ermert Germany 17 219 0.3× 210 0.3× 591 1.1× 279 1.3× 171 1.2× 21 1.2k
Chaitanya Vuppusetty United Kingdom 13 530 0.8× 344 0.6× 321 0.6× 158 0.7× 19 0.1× 21 1.1k
Stephanie Yacoubian United States 5 337 0.5× 208 0.3× 98 0.2× 376 1.7× 138 0.9× 6 1.3k
Shinji Sakaue Japan 13 503 0.7× 700 1.1× 522 1.0× 201 0.9× 78 0.5× 22 1.5k
B. Moseley Waite United States 16 337 0.5× 175 0.3× 214 0.4× 198 0.9× 83 0.6× 28 909

Countries citing papers authored by Rolf Beume

Since Specialization
Citations

This map shows the geographic impact of Rolf Beume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Beume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Beume more than expected).

Fields of papers citing papers by Rolf Beume

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Beume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Beume. The network helps show where Rolf Beume may publish in the future.

Co-authorship network of co-authors of Rolf Beume

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Beume. A scholar is included among the top collaborators of Rolf Beume based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Beume. Rolf Beume is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Totani, Licia, Concetta Amore, Giuseppe Dell’Elba, et al.. (2015). Roflumilast inhibits leukocyte–platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes. Journal of Thrombosis and Haemostasis. 14(1). 191–204. 29 indexed citations
2.
Milara, Javier, M Armengot, Hermann Tenor, et al.. (2012). Roflumilast N‐oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smokein vitro. British Journal of Pharmacology. 166(8). 2243–2262. 73 indexed citations
3.
Hanauer, Guido, et al.. (2012). The glucose-lowering effects of the PDE4 inhibitors roflumilast and roflumilast-N-oxide in db/db mice. Diabetologia. 55(10). 2779–2788. 51 indexed citations
4.
Schudt, Christian, Armin Hatzelmann, Rolf Beume, & Hermann Tenor. (2011). Phosphodiesterase Inhibitors: History of Pharmacology. Handbook of experimental pharmacology. 1–46. 38 indexed citations
5.
Tenor, Hermann, Armin Hatzelmann, Rolf Beume, et al.. (2011). Pharmacology, Clinical Efficacy, and Tolerability of Phosphodiesterase-4 Inhibitors: Impact of Human Pharmacokinetics. Handbook of experimental pharmacology. 85–119. 35 indexed citations
6.
Hatzelmann, Armin, Esteban Morcillo, Giuseppe Lungarella, et al.. (2010). The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics. 23(4). 235–256. 248 indexed citations
7.
Sabatini, Federica, Loredana Petecchia, Silvia Boero, et al.. (2010). A phosphodiesterase 4 inhibitor, roflumilast N-oxide, inhibits human lung fibroblast functions in vitro. Pulmonary Pharmacology & Therapeutics. 23(4). 283–291. 32 indexed citations
8.
Hoymann, Heinz-Gerd, Lutz Wollin, Meike Müller, et al.. (2009). Effects of the Phosphodiesterase Type 4 Inhibitor Roflumilast on Early and Late Allergic Response and Airway Hyperresponsiveness in <i>Aspergillus-fumigatus</i>-Sensitized Mice. Pharmacology. 83(3). 188–195. 8 indexed citations
9.
Martorana, Piero A., Benedetta Lunghi, Monica Lucattelli, et al.. (2008). Effect of roflumilast on inflammatory cells in the lungs of cigarette smoke-exposed mice. BMC Pulmonary Medicine. 8(1). 17–17. 39 indexed citations
10.
Martorana, Piero A., et al.. (2007). Roflumilast prevents the increase in inflammatory cells in the lungs of mice chronically exposed to cigarette smoke: an immunohistochemical study. Use Siena air (University of Siena).
11.
Martorana, Piero A., Rolf Beume, Monica Lucattelli, Lutz Wollin, & Giuseppe Lungarella. (2005). Roflumilast Fully Prevents Emphysema in Mice Chronically Exposed to Cigarette Smoke. American Journal of Respiratory and Critical Care Medicine. 172(7). 848–853. 164 indexed citations
12.
Wollin, Lutz, et al.. (2005). Roflumilast Inhibition of Pulmonary Leukotriene Production and Bronchoconstriction in Ovalbumin-Sensitized and -Challenged Guinea Pigs. Journal of Asthma. 42(10). 873–878. 9 indexed citations
13.
Wollin, Lutz, et al.. (2005). Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors. Pulmonary Pharmacology & Therapeutics. 19(5). 343–352. 44 indexed citations
14.
Kumar, Rakesh, Cristan Herbert, Paul S. Thomas, et al.. (2003). Inhibition of Inflammation and Remodeling by Roflumilast and Dexamethasone in Murine Chronic Asthma. Journal of Pharmacology and Experimental Therapeutics. 307(1). 349–355. 132 indexed citations
15.
Bundschuh, Daniela S., Manfrid Eltze, Johannes Barsig, et al.. (2001). In Vivo Efficacy in Airway Disease Models of Roflumilast, a Novel Orally Active PDE4 Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 297(1). 280–290. 200 indexed citations
16.
Barsig, Johannes, et al.. (2001). FRI0018 Protection by phosphodiesterase-4 inhibitor roflumilast of mice against collagen-induced arthritis. Annals of the Rheumatic Diseases. 60. A452–A452. 2 indexed citations
17.
Beume, Rolf, et al.. (1996). Automatic leukocyte differentiation in bronchoalveolar lavage fluids of guinea pigs and Brown-Norway rats. Journal of Pharmacological and Toxicological Methods. 35(2). 91–99. 6 indexed citations
18.
Hoymann, H. G., et al.. (1994). Comparative Investigation of the Effects of Zardaverine and Theophylline on Pulmonary Function in Rats. Experimental Lung Research. 20(3). 235–250. 17 indexed citations
19.
Häfner, D., et al.. (1993). Randomized Placebo-controlled Study on the Characteristics and Duration of Action of Surfactant Treatment in Premature Lambs. Pulmonary Pharmacology. 6(4). 255–262. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hermann Tenor Breakdown of academic impact, for papers by M A Giembycz Breakdown of academic impact, for papers by L. Daffonchio Breakdown of academic impact, for papers by Piper Pj Breakdown of academic impact, for papers by Stephen M. Spaethe Breakdown of academic impact, for papers by Monika Ermert Breakdown of academic impact, for papers by Chaitanya Vuppusetty Breakdown of academic impact, for papers by Stephanie Yacoubian Breakdown of academic impact, for papers by Shinji Sakaue Breakdown of academic impact, for papers by B. Moseley Waite
Rankless by CCL
2026